Manage Your Liver
Q:

What is NCD? What problem is it causing? How can the problem be solved?

A:

NCD stands for non-communicable disease, also known as “lifestyle disease”. This type of diseases are not passed from person to person. They are usually chronic diseases that progress slowly throughout a long period of time. NCDs are preventable and the most common causes are smoking, alcohol abuse, unbalanced diets and lack of physical activity. According to WHO, NCD nowadays overtook infectious diseases as the principle driver of global mortality.

 

The 4 main types of NCDs are cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. They account for over 80% of all NCD deaths. [1]

 

The rise of NCDs has brought serious socioeconomic impacts. High health care costs for treating NCDs not only become a heavy burden for governments but also drive families into poverty. Premature deaths (death before the age of 70) are also increasing globally and most occur in middle and low-income countries. This is mainly because developing countries generally have lower capacity for the prevention and control of NCDs. Although high-income groups also suffer from unhealthy diet and lifestyle, they can access better medical services and products that can protect them. On the contrary, some of these treatments are simply unaffordable for the less privileged.

Dealing with NCDs requires effort from both individuals and governments. The individual must adopt behavior changes and lead a healthy lifestyle in order to minimize the risk of NCDs. However, it is up to the governments to develop policies and revolutionize public health care to tackle the core of this problem. NCDs are driven by the effects of globalization, rapid urbanization and population ageing – factors over which the individual has little control and over which the conventional health sector also has little power.

World Health Organization (WHO) has recommended a set of low-cost policy interventions that focus on two main aspects: prevention and detection. [2]

 

Prevention

To lessen the NCD burden, WHO put forward a global action plan that aims to reduce the number of premature deaths through nine global targets. The targets include to reduce alcohol abuse, insufficient physical activity, salt/sodium intake, tobacco use and hypertension; halt the rise of obesity and diabetes; and improve coverage of treatment for the prevention of cardiovascular diseases and access to basic technologies and medicines. Some of the suggested measures include banning all forms of tobacco and alcohol advertising, replacing trans fats with polyunsaturated fats and promoting breastfeeding.

Apart from the above, we also recommend people to maintain their liver and kidney health, as normal liver and kidney functions are closely linked with preventing modern diseases. 

 

Detection

“Disease surveillance is further needed to detect NCDs and to detect them early, when patient management has the best chance of success and at the lowest cost.” – Dr. Margaret Chan, WHO Director-General [3]

Regular checkups and screening is important as early detection and diagnosis can result in timely treatment of NCDs. The success rate of treatment is higher and treatment is more cost-effective in the early stages. WHO also recommends the development of more user-friendly technologies for easy diagnosis by health workers and self-monitoring by patients for diseases such as hypertension and diabetes.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Chronic liver disease is a serious condition and a leading cause of death among people across the world. The number of liver cancer cases have over took to become the leading cancer since 2014, and fatty liver disease/ NASH is set to become the leading cause of liver transplant in 2020. Protects your liver In the view of this, liver protection to prevent chronic liver disease is quickly becoming more important then ever. So what can we do
A:
ALT and AST are enzymes that are normally predominantly contained within liver cells. If the liver is injured or damaged, the liver cells spill these enzymes into the blood, raising the AST and ALT enzyme levels in the blood, and we can use it as a measurement of liver injury.   What are the differences between ALT and AST? AST is normally found in a variety of tissues including liver, heart, muscle, kidney, and the brain. It is released int
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us